Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Daraxonrasib for Previously Treated RAS-Mutant Non-Small-Cell Lung Cancer.
Journal: The New England journal of medicine
Published: September 02, 2026
Inflammatory Myofibroblastic Tumor: A Case Report of Neoadjuvant Alectinib and Summary of Single-Institution Molecular Data.
Journal: JCO precision oncology
Published: June 08, 2026
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer.
Journal: The New England journal of medicine
Published: May 06, 2026
Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer.
Journal: The New England journal of medicine
Published: March 25, 2026
Therapeutic inhibition of RAS in non-small cell lung cancer.
Journal: Frontiers in oncology
Published: February 26, 2026
Spatiotemporal lineage tracing reveals the dynamic spatial architecture of tumor growth and metastasis.
Journal: Nature genetics
Published: December 10, 2025
Multi-Institution Analysis of Tarlatamab for the Treatment of EGFR-Mutant Transformed Small Cell Lung Cancer.
Journal: JCO precision oncology
Published: October 30, 2025
Phase Ib study of berzosertib, carboplatin, gemcitabine, and pembrolizumab in patients with squamous nonsmall lung cancer (ETCTN 10313).
Journal: The oncologist
Published: July 09, 2025
Anticancer activity of RAS-GTP inhibition in cholangiocarcinoma.
Journal: Cancer cell
Published: June 18, 2025
The impact of eligibility criteria on Kirsten rat sarcoma G12C inhibitor trials in patients with non-small cell lung cancer.
Journal: Journal of the National Cancer Institute
Published: April 24, 2025
Genomic and Epigenomic ctDNA Profiling in Liquid Biopsies from Heavily Pretreated Patients with DNA Damage Response-Deficient Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 14, 2025
Last Updated: 09/26/2026